Literature DB >> 9579927

Failure of absorption of gabapentin after rectal administration.

R L Kriel1, A K Birnbaum, J C Cloyd, B J Ricker, C Jones Saete, K J Caruso.   

Abstract

PURPOSE: We wished to determine the extent of absorption of gabapentin (GBP) after rectal administration to children on maintenance therapy.
METHODS: Two children scheduled for extensive surgery received GBP rectally and orally. A pharmacokinetic profile was derived after each route of administration.
RESULTS: Serum GBP levels after rectal administration decreased at a rate similar to their rate of decrease after oral administration. However, GBP concentrations were much lower after rectal administration; therefore, we concluded that the aqueous solution was poorly absorbed rectally. The GBP half-life (t1/2) for the 2 children after oral doses were 4.2 and 4.8 h.
CONCLUSIONS: Rectal administration of GBP is not satisfactory when oral administration is interrupted. When oral GBP therapy is temporarily discontinued, clinicians should consider administration of alternative antiepileptic drugs (AEDs) that can be administered parenterally or rectally.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9579927     DOI: 10.1111/j.1528-1157.1997.tb01223.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  5 in total

Review 1.  Amino Acids in the Development of Prodrugs.

Authors:  Nuno Vale; Abigail Ferreira; Joana Matos; Paula Fresco; Maria João Gouveia
Journal:  Molecules       Date:  2018-09-11       Impact factor: 4.411

2.  A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome.

Authors:  Daniel O Lee; Ronald B Ziman; A Thomas Perkins; J Steven Poceta; Arthur S Walters; Ronald W Barrett
Journal:  J Clin Sleep Med       Date:  2011-06-15       Impact factor: 4.062

3.  Relative bioavailability, metabolism and tolerability of rectally administered oxcarbazepine suspension.

Authors:  Pamela L Clemens; James C Cloyd; Robert L Kriel; Rory P Remmel
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

4.  Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study.

Authors:  Richard K Bogan; Michel A Cramer Bornemann; Clete A Kushida; Pierre V Trân; Ronald W Barrett
Journal:  Mayo Clin Proc       Date:  2010-06       Impact factor: 7.616

5.  Once-daily gastroretentive gabapentin for the management of postherpetic neuralgia: an update for clinicians.

Authors:  Gordon Irving
Journal:  Ther Adv Chronic Dis       Date:  2012-09       Impact factor: 5.091

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.